Developing Countries: Disease Control:Written question - 212341

Q
Asked by Nic Dakin
(Scunthorpe)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 28 October 2014
Department for International Development
Developing Countries: Disease Control
Commons
To ask the Secretary of State for International Development, what support her Department gives to (a) the European and Devoloping Countries Clinical Trials Partnership, (b) other innovative financing partnerships to develop new global health commodities for diseases of poverty including HIV/Aids and tuberculosis, (c) the TB Alliance, (d) the International Aids Vaccine Initiative and (e) other product development partnerships.
A
Answered by: Lynne Featherstone
Answered on: 03 November 2014

The UK Medical Research Council (MRC) leads the UK Government relationship with the European and Developing Countries Clinical Trials Partnership (EDCTP). Over the period 2013-2018, DFID will provide £10 million to EDCTP through the MRC. In addition DFID support for product development research is counted as a Member State contribution to EDCTP.

DFID contributes to a number of innovative product development partnerships (PDPs) for the development of drugs, vaccines, diagnostics and other technologies for diseases of poverty. Funding of £138 million for 2013-2018 was announced in August 2013 and includes support for the TB Alliance, the International AIDS vaccine Initiative and eight other PDPs (details of the awards were published in August 2013 and can be found at:

https://www.gov.uk/government/news/dfid-invests-to-save-millions-from-deadly-diseases). In addition over the period 2012-2017, DFID will provide £6.5 million for the Saving Lives at Birth programme in partnership with the Bill and Melinda Gates Foundation, US Government, Norwegian Government and Grand Challenges Canada. This programme is supporting new technologies to prevent mothers and babies dying at birth.

Share this page